Biotechnology Stocks I Performance Guide: Catalyst Pharmaceuticals, Inc. (CPRX)
CPRX has no dividends
Table and Chart of CPRX Performance
See what a $1,000 investment in CPRX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| CPRX Returns | |
|---|---|
| Start Date | Dec-31-2013 |
| Start Price | $1.95 |
| End Date | Dec-01-2023 |
| End Price | $14.82 |
| # Prices | 121 |
| Min Date | May-31-2016 |
| Min Price | $0.62 |
| Max Date | Dec-30-2022 |
| Max Price | $18.60 |
| Total Return | 660.00% |
| Annualized Return | 22.28% |
| Current Value of $1,000 Purchase | $7,600 |
| Number Returns | 7,260 |
| Average Return | 184.18% |
| Number Profitable Returns | 5,876 |
| Percent Profitable Returns | 80.94% |
| Number Unprofitable Returns | 1,384 |
| Percent Unprofitable Returns | 19.06% |
| Profitable to Unprofitable Returns Ratio | 4.25 |
| CPRX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,579,975,000 | Price to Sales | 4.54 |
| Earnings per Share | $0.5500 |
| PE Ratio | 26.95 |
| PE to Growth Ratio | 0 |
| Price to Book | 4.539 |
| PRICE DATA | |
| 52 Week High | $22.11 |
| 52 Week Low | $11.09 |
| Analyst Target Price | $23.3 |
| 50-Day Moving Average | $12.95 |
| 200-Day Moving Average | $13.97 |
| FINANCIAL DATA | |
| Revenue per Share | $3.295 |
| Revenue | $348,393,000 |
| Profit Margin | 17.8% |
| Return on Equity | 0.201% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
CPRX Compare Returns with S&P 500
CPRX Trendline Chart